中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

8 records (took 0.016 seconds)

    CARRIER FOR DRY ADSORBENT FOR CARBON DIOXIDE INCLUDING SPHERICAL SILICA WHOSE SURFACE IS ENGRAVED IN THE FORM OF NANOWIRES AND METHOD FOR PREPARING THE SAME
    3.
    发明申请
    CARRIER FOR DRY ADSORBENT FOR CARBON DIOXIDE INCLUDING SPHERICAL SILICA WHOSE SURFACE IS ENGRAVED IN THE FORM OF NANOWIRES AND METHOD FOR PREPARING THE SAME 有权
    用于二氧化碳的干燥吸附剂的载体，包括在纳米颗粒形式中形成表面的球形二氧化硅及其制备方法

    公开(公告)号：US20160136615A1

    公开(公告)日：2016-05-19

    申请号：US14945127

    申请日：2015-11-18

    Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY

    Inventor： Hyung Hee CHO ,  Hokyu Moon ,  Geehong Choi ,  Beom Seok Kim ,  Donghwi Lee ,  Hwanseong Lee ,  Hoanju Yoo ,  Dong II Shim

    IPC: B01J21/08 ,  B01J37/12 ,  B01J37/06 ,  B01J35/08

    CPC classification number: B01J21/08 ,  B01J20/103 ,  B01J20/3204 ,  B01J20/3236 ,  B01J20/3293 ,  B01J35/08 ,  B01J37/06 ,  B01J37/12 ,  Y02C10/08

    Abstract: Provided are a carrier for a dry adsorbent for carbon dioxide, including spherical silica whose surface is engraved in the form of nanowires, and a method for preparing the same. Although the carrier for a dry adsorbent for carbon dioxide including spherical silica that has nanowires on the surface thereof has a very non-uniform shape, it serves better as a host structure adsorbing carbon dioxide as compared to the conventional carrier for a carbon dioxide adsorbent, and thus may be used for a host-guest adsorbent applicable to a fluidized bed process. In addition, the method for preparing a carrier for a carbon dioxide adsorbent provides nanowire-coated silicon spheres having an increased surface roughness and an increased surface area, thereby providing increased carbon dioxide capturing efficiency. Further, since the method for forming nanowires is simple, it is easy to carry out mass production without any separate process, thereby providing excellent cost efficiency.

    Abstract translation: 本发明提供一种用于二氧化碳干吸附剂的载体，包括其表面以纳米线形式雕刻的球形二氧化硅及其制备方法。 尽管包括其表面上具有纳米线的球形二氧化硅的二氧化碳干吸附剂的载体具有非常不均匀的形状，但是与用于二氧化碳吸附剂的常规载体相比，其作为吸附二氧化碳的主体结构更有效， 因此可用于适用于流化床工艺的主体 - 客体吸附剂。 此外，制备二氧化碳吸附剂载体的方法提供具有增加的表面粗糙度和增加的表面积的纳米线涂覆的硅球，从而提供增加的二氧化碳捕获效率。 此外，由于纳米线的形成方法简单，因此容易进行大量生产而不进行任何单独的处理，从而提供优异的成本效率。

    Pharmaceutical Composition for Preventing or Treating Adverse Drug Reactions by Statin
    4.
    发明申请
    Pharmaceutical Composition for Preventing or Treating Adverse Drug Reactions by Statin 审中-公开

    公开(公告)号：US20200261480A1

    公开(公告)日：2020-08-20

    申请号：US16761764

    申请日：2018-11-05

    Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY

    Inventor： Beom Seok Kim ,  Chul Hoon Kim ,  Jong Jin Yoon

    IPC: A61K31/683 ,  A61K31/191 ,  A61K31/357 ,  A61K31/137 ,  A61K31/496

    Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating statin-induced adverse effects or a pharmaceutical composition for co-administration with statin, the pharmaceutical composition containing, as an active ingredient, at least one selected from the group consisting of an isoprenoid-based compound, zaragozic acid, terbinafine, and ketoconazole. The pharmaceutical composition according to the present disclosure may prevent and/or treat adverse statin effects that can be induced by statin, that is, can be induced at any time by oxisterols present at abnormal levels in the body. The pharmaceutical composition can not only treat but also prevent the adverse effects of various statin therapeutics whose use has recently increased rapidly, and thus it is expected that the pharmaceutical composition can be widely used for various diseases and the utilization thereof can further be increased.

    Pharmaceutical Composition for Preventing or Treating Adverse Drug Reactions by Statin
    5.
    发明公开
    Pharmaceutical Composition for Preventing or Treating Adverse Drug Reactions by Statin 审中-公开

    公开(公告)号：US20230210874A1

    公开(公告)日：2023-07-06

    申请号：US18063159

    申请日：2022-12-08

    Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY

    Inventor： Beom Seok Kim ,  Chul Hoon Kim ,  Jong Jin Yoon

    IPC: A61K31/357 ,  A61K45/06 ,  A61P39/00 ,  A61K31/40

    CPC classification number: A61K31/357 ,  A61K45/06 ,  A61P39/00 ,  A61K31/40

    Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating statin-induced adverse effects or a pharmaceutical composition for co-administration with statin, the pharmaceutical composition containing, as an active ingredient, at least one selected from the group consisting of an isoprenoid-based compound, zaragozic acid, terbinafine, and ketoconazole. The pharmaceutical composition according to the present disclosure may prevent and/or treat adverse statin effects that can be induced by statin, that is, can be induced at any time by oxisterols present at abnormal levels in the body. The pharmaceutical composition can not only treat but also prevent the adverse effects of various statin therapeutics whose use has recently increased rapidly, and thus it is expected that the pharmaceutical composition can be widely used for various diseases and the utilization thereof can further be increased.

Patent Agency Ranking